Back to UBS Group AG UBS Group AG

ANVSANVS
Showing 8 of 19 quarters

Position history for UBS Group AGUBS Group AG's holdings in ANNOVIS BIO INC

UBS Group AG holds 11,775 shares of ANVS (ANNOVIS BIO INC), worth $21,901 as of 2026-Q2. The position was decreased (-45.3% shares).

Current Value

$21,901

Current Shares

11,775

Total Value Change

+$7,014

Total Shares Change

+9,928

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
11,775
-45.3%
$21,9010.0%$1.86
0
2026-Q1
Decreased
21,538
-29.7%
$48,0300.0%$2.58
0
2025-Q4
Increased
30,643
+4740.9%
$106,0250.0%$3.46
24
2025-Q3
Decreased
633
-97.6%
$1,3100.0%$2.04
0
2025-Q2
Decreased
26,317
-83.6%
$57,1080.0%$2.05
0
2025-Q1
Increased
160,876
+230.1%
$241,3150.0%$1.65
25
2024-Q4
Increased
48,736
+2538.7%
$245,1420.0%$5.08
25
2024-Q3
Decreased
1,847
-85.8%
$14,8870.0%$8.10
0

Other major holders of ANVS: VOLORIDGE INVESTMENT MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used